CLRB - Cellectar Biosciences, Inc.
2.75
-0.010 -0.364%
Share volume: 114,458
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.01
0.00%
Summary score
22%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.48%
Return on assets
-26.39%
Return on sales
0%
Return on invested capital
570.91%
Total debt ratio
19.64%
Debt ratio change over timeo
0%
Current Ratio
5.37%
Quick Ratio
0%
Cash Position Ratio
4.97%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.68%
Return on assets
-28.42%
Return on sales
0%
Return on invested capital
171.93%
Total debt ratio
25.95%
Debt ratio change over timeo
0%
Current Ratio
4.65%
Quick Ratio
0%
Cash Position Ratio
4.35%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.07%
Return on assets
-15.19%
Return on sales
0%
Return on invested capital
143.84%
Total debt ratio
16.21%
Debt ratio change over time
0%
Current Ratio
6.94%
Quick Ratio
0%
Cash Position Ratio
6.76%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLRB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -36.48% | 17.45% | 4.69% | -3.05% |
| Return on assets | -26.39% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 570.91% | 5.2% | 4.37% | 5.09% |
| Profitability | 25% | 67% | 50% | 50% |
| Total debt ratio | 19.64% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 5% | 19% | 18% | 50% |
| Current Ratio | 4.65% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 4.35% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 27% | 35% | 36% |
| Short-term ratios | CLRB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -40.68% | 44.06% | 6.24% | -25.62% |
| Return on assets | -28.42% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 171.93% | 9.69% | 4.96% | 8.14% |
| Profitability | 25% | 73% | 45% | 47% |
| Total debt ratio | 25.95% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 6% | 22% | 35% | 50% |
| Current Ratio | 4.65% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 4.35% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 19% | 23% | 45% |